New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
11:21 EDTINO, SHPG, IRBT, CMG, LXK, PSEC, CROX, ATHN, VMWOptions with decreasing implied volatility
Options with decreasing implied volatility: INO SHPG IRBT CMG LXK PSEC CROX ATHN VMW
News For INO;SHPG;IRBT;CMG;LXK;PSEC;CROX;ATHN;VMW From The Last 14 Days
Check below for free stories on INO;SHPG;IRBT;CMG;LXK;PSEC;CROX;ATHN;VMW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
September 11, 2014
07:43 EDTCROXCrocs downgraded to Neutral from Buy at Buckingham
Buckingham downgraded Crocs to Neutral based on slowing sales trends and incremental FX pressure. The firm does not believe a major sales inflection will occur until Spring 2016 at the earliest and notes Croc's profit improvement plan does not provide a time-frame for growth. Price target lowered to $13 from $20.
07:28 EDTPSECPR Newswire to hold a virtual conference
Subscribe for More Information
07:07 EDTVMWEMC to explore selling VMware stake, NY Post reports
Subscribe for More Information
September 10, 2014
17:36 EDTCMGPenn State Chipotle closed after workers quit, The Daily Collegian says
Subscribe for More Information
10:00 EDTVMWOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:42 EDTCMGChipotle price target raised to $775 from $700 at Oppenheimer
Subscribe for More Information
08:37 EDTSHPGMedgenics appoints Scott Applebaum as Chief Legal Officer
Subscribe for More Information
07:06 EDTSHPGSangamo plans to submit IND application for hemophilia B in 2Q15
Sangamo BioSciences (SGMO) plans to submit an Investigational New Drug application for the treatment of hemophilia B in Q2 2015. This program, partnered with Shire (SHPG), is the first therapeutic application of Sangamo's zinc finger nuclease-mediated In Vivo Protein Replacement Platform. Sangamo is developing the IVPRP as a generally applicable strategy to provide a one-time, permanent genetic cure for monogenic diseases that are currently managed by protein replacement therapy, which involves costly repeat infusions over the lifetime of the patient.
September 9, 2014
19:39 EDTVMWVMware initiated with a Buy at Maxim
Target $120.00.
13:02 EDTLXKArtisan Partners reduces passive stake in Lexmark to 2.3% from 8.3%
Subscribe for More Information
12:08 EDTINOOptions with increasing implied volatility
Subscribe for More Information
10:35 EDTCMGGundlach says Chipotle shares 'horribly' overvalued
DoubleLine Capital's Jeff Gundlach is speaking on CNBC.
05:36 EDTVMWVMware, Capgemini announce strategic partnership
Subscribe for More Information
September 8, 2014
09:01 EDTIRBTiRobot wins contracts valued at $9.6M from Canadian National Defence Dept
iRobot has been awarded multi-year contracts with an initial value of $9.6M by the Canadian Department of National Defence. The contracts, awarded after a competitive bidding process, call for the delivery of 20 iRobot 510 PackBot CBRN Recce Systems, training and future product lifecycle support. All systems under the contract are expected to be delivered by April 2015.
08:31 EDTLXKLexmark announces results of Readsoft tender offer
Subscribe for More Information
September 5, 2014
09:48 EDTIRBTDyson reveals robotic vacuum cleaner that rivals Roomba, IB Times says
Subscribe for More Information
September 4, 2014
11:20 EDTVMWStocks with increasing options volume
Stocks with increasing options volume: BP VMW SCTY X GE MBLY VALE DDD
11:05 EDTINOOptions with increasing implied volatility
Subscribe for More Information
09:02 EDTINOInovio to list on NASDAQ
Subscribe for More Information
September 3, 2014
12:19 EDTPSEC, SHPGOptions with increasing implied volatility
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use